{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T15:02:55Z","timestamp":1761058975288},"reference-count":37,"publisher":"Wiley","issue":"S6","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":5417,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Cardiol"],"published-print":{"date-parts":[[2000,11]]},"DOI":"10.1002\/clc.4960231106","type":"journal-article","created":{"date-parts":[[2009,7,16]],"date-time":"2009-07-16T06:55:37Z","timestamp":1247727337000},"page":"18-22","source":"Crossref","is-referenced-by-count":16,"special_numbering":"supplement S6","title":["Value of Antiplatelet Therapy in Preventing Thrombotic Events in Generalized Vascular Disease"],"prefix":"10.1002","volume":"23","author":[{"given":"G.","family":"Montalescot","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","reference":[{"key":"10.1002\/clc.4960231106-BIB1","volume-title":"2000 Heart and Stroke Statistical Update.","author":"American Heart Association","year":"1999"},{"key":"10.1002\/clc.4960231106-BIB2","volume-title":"The World Health Report 1999: Making a Difference.","author":"World Health Organization","year":"1999"},{"key":"10.1002\/clc.4960231106-BIB3","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1159\/000116272","article-title":"Risk of recurrent stroke, myocardial infarction and epilepsy during long-term follow-up after stroke","volume":"28","author":"Viitanen","year":"1988","journal-title":"Eur Neurol"},{"key":"10.1002\/clc.4960231106-BIB4","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1212\/WNL.44.4.626","article-title":"Predictors of mortality and recurrence after hospitalized cerebral infarction in an urban community: The Northern Manhattan Stroke Study","volume":"44","author":"Sacco","year":"1994","journal-title":"Neurology"},{"key":"10.1002\/clc.4960231106-BIB5","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1016\/S0140-6736(96)09457-3","article-title":"A randomised, blinded trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE)","volume":"348","author":"CAPRIE Steering Committee","year":"1996","journal-title":"Lancet"},{"issue":"6921","key":"10.1002\/clc.4960231106-BIB6","first-page":"1540","article-title":"Collaborative overview of randomised trials of antiplatelet therapy-I: prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients [published erratum appears in","volume":"308","author":"Antiplatelet Trialists' Collaboration","year":"1994","journal-title":"Br Med J"},{"key":"10.1002\/clc.4960231106-BIB7","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1136\/bmj.308.6921.81","volume":"308","year":"1994","unstructured":"Br Med J 1994; 308: 81-106","journal-title":"Br Med J"},{"key":"10.1002\/clc.4960231106-BIB8","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1016\/S0002-9149(99)00421-X","article-title":"Effect of abciximab on the pattern of reperfusion in patients with acute myocardial infarction treated with primary angioplasty. RAPPORT investigators. ReoPro And Primary PTCA Organization and Randomized Trial","volume":"84","author":"Brener","year":"1999","journal-title":"Am J Cardiol"},{"key":"10.1002\/clc.4960231106-BIB9","first-page":"1","article-title":"Abciximab associated with primary angioplasty and stenting in acute myocardial infarction: The ADMIRAL Study, 30-day final results (abstr 446)","volume":"100","author":"Montalescot","year":"2000","journal-title":"Circulation"},{"key":"10.1002\/clc.4960231106-BIB10","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1161\/01.CIR.96.5.1445","article-title":"Effects of platelet glycoprotein IIb\/IIIa blockade with tirofiban on adverse cardiac events in patients with unstable angina or acute myocardial infarction undergoing coronary angioplasty","volume":"96","author":"The RESTORE Investigators","year":"1997","journal-title":"Circulation"},{"key":"10.1002\/clc.4960231106-BIB11","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1056\/NEJM199706123362401","article-title":"Platelet glycoprotein IIb\/IIIa receptor blockade and low-dose heparin during percutaneous coronary revascularization","volume":"336","author":"EPILOG Investigators","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1002\/clc.4960231106-BIB12","first-page":"I","article-title":"Pretreatment with ticlopidine prior to stenting is associated with a substantial decrease in complications: Data from the EPISTENT trial (abstr 3016)","volume":"98","author":"Steinhubl","year":"1998","journal-title":"Circulation"},{"key":"10.1002\/clc.4960231106-BIB13","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1161\/01.CIR.97.4.340","article-title":"Randomized trial of an oral platelet glycoprotein IIb\/IIIa antagonist, sibrafiban, in patients after an acute coronary syndrome. Results of the TIMI 12 trial","volume":"97","author":"Cannon","year":"1998","journal-title":"Circulation"},{"key":"10.1002\/clc.4960231106-BIB14","volume-title":"Antiplatelet Therapy in Clinical Practice","author":"Cannon","year":"1999"},{"key":"10.1002\/clc.4960231106-BIB15","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1056\/NEJM198908243210804","volume":"321","author":"Hass","year":"1989","journal-title":"N Engl J Med"},{"key":"10.1002\/clc.4960231106-BIB16","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1161\/01.STR.23.12.1723","volume":"23","author":"Harbison","year":"1992","journal-title":"Stroke"},{"key":"10.1002\/clc.4960231106-BIB17","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1161\/01.STR.24.10.1452","article-title":"Efficacy of ticlopidine and aspirin for prevention of reversible cerebrovascular ischemic events. The Ticlopidine Aspirin Stroke Study","volume":"24","author":"Bellavance","year":"1993","journal-title":"Stroke"},{"key":"10.1002\/clc.4960231106-BIB18","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1111\/j.1527-3466.1993.tb00275.x","article-title":"Clopidogrel, a novel antiplatelet and antithrombotic agent","volume":"11","author":"Herbert","year":"1993","journal-title":"Cardiovasc Drug Rev"},{"key":"10.1002\/clc.4960231106-BIB19","first-page":"I","article-title":"Benefit of clopidogrel in patients with coronary disease (abstr 2608)","volume":"96","author":"Gent","year":"1997","journal-title":"Circulation"},{"key":"10.1002\/clc.4960231106-BIB20","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.1161\/01.CIR.98.22.2461","article-title":"Clopidogrel inhibition of stent, graft, and vascular thrombogenesis with antithrombotic enhancement by aspirin in nonhuman primates","volume":"98","author":"Harker","year":"1998","journal-title":"Circulation"},{"key":"10.1002\/clc.4960231106-BIB21","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1001\/archneur.1993.00540070030010","article-title":"Antiplatelet therapy is effective in primary prevention of myocardial infarction in patients with a previous cerebrovascular ischemic event","volume":"50","author":"Sivenius","year":"1993","journal-title":"Arch Neurol"},{"key":"10.1002\/clc.4960231106-BIB22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0022-510X(96)00308-5","article-title":"European Stroke Prevention Study 2. Dipyridamole and acetylsalicylic acid in the secondary prevention of stroke","volume":"143","author":"Diener","year":"1996","journal-title":"J Neurol Sci"},{"key":"10.1002\/clc.4960231106-BIB23","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1253\/jcj.61.38","article-title":"Aspirin plus either dipyridamole or ticlopidine is effective in preventing recurrent myocardial infarction. Secondary Prevention Group","volume":"61","author":"Ishikawa","year":"1997","journal-title":"Jpn Circ J"},{"key":"10.1002\/clc.4960231106-BIB24","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1056\/NEJM199812033392303","volume":"339","author":"Leon","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1002\/clc.4960231106-BIB25","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1161\/01.CIR.98.16.1597","article-title":"Randomized multicenter comparison of conventional anticoagulation versus antiplatelet therapy in unplanned and elective coronary stenting. The Full Anticoagulation Versus Aspirin and Ticlopidine (FANTASTIC) Study","volume":"98","author":"Bertrand","year":"1998","journal-title":"Circulation"},{"key":"10.1002\/clc.4960231106-BIB26","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1161\/01.CIR.93.2.215","article-title":"A randomized comparison of combined ticlopidine and aspirin therapy versus aspirin therapy alone after successful intravascular ultrasound-guided stent implantation (see comments)","volume":"93","author":"Hall","year":"1996","journal-title":"Circulation"},{"key":"10.1002\/clc.4960231106-BIB27","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.1161\/01.CIR.98.20.2126","volume":"98","author":"Urban","year":"1998","journal-title":"Circulation"},{"key":"10.1002\/clc.4960231106-BIB28","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1016\/S0002-9149(96)00532-2","article-title":"Comparison of aspirin alone versus aspirin plus ticlopidine after coronary artery stenting","volume":"78","author":"Goods","year":"1996","journal-title":"Am J Cardiol"},{"key":"10.1002\/clc.4960231106-BIB29","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1056\/NEJM199604253341702","article-title":"A randomized comparison of antiplatelet and anticoagulant therapy after the placement of coronary-artery stents","volume":"334","author":"Sch\u00f6mig","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1002\/clc.4960231106-BIB30","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1016\/S0735-1097(97)00073-9","article-title":"Antiplatelet effect of ticlopidine after coronary stenting","volume":"29","author":"Neumann","year":"1997","journal-title":"J Am Coll Cardiol"},{"key":"10.1002\/clc.4960231106-BIB31","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.1016\/S0735-1097(99)00443-X","volume":"34","author":"Mishkel","year":"1999","journal-title":"J Am Coll Cardiol"},{"key":"10.1002\/clc.4960231106-BIB32","doi-asserted-by":"crossref","first-page":"2364","DOI":"10.1161\/01.CIR.99.18.2364","article-title":"Effectiveness of clopidogrel and aspirin versus ticlopidine and aspirin in preventing stent thrombosis after coronary stent implantation","volume":"99","author":"Moussa","year":"1999","journal-title":"Circulation"},{"key":"10.1002\/clc.4960231106-BIB33","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1161\/01.CIR.101.6.590","article-title":"A randomized comparison of clopidogrel and aspirin versus ticlopidine and aspirin after the placement of coronary-artery stents","volume":"101","author":"M\u00fcller","year":"2000","journal-title":"Circulation"},{"key":"10.1002\/clc.4960231106-BIB34","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/S0002-9149(99)00420-8","article-title":"Effectiveness of aspirin and clopidogrel combination therapy in coronary stenting","volume":"84","author":"Jauhar","year":"1999","journal-title":"Am J Cardiol"},{"key":"10.1002\/clc.4960231106-BIB35","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1161\/01.CIR.102.6.624","article-title":"Double-blind study of the safety of clopidogrel with and without a loading dose in combination with aspirin compared with ticlopidine in combination with aspirin after coronary stenting. The CLASSICS Study","volume":"102","author":"Bertrand","year":"2000","journal-title":"Circulation"},{"key":"10.1002\/clc.4960231106-BIB36","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1016\/S0735-1097(99)00442-8","article-title":"Clopidogrel versus ticlopidine after intracoronary stent placement","volume":"34","author":"Berger","year":"1999","journal-title":"J Am Coll Cardiol"},{"issue":"6","key":"10.1002\/clc.4960231106-BIB37","first-page":"659","article-title":"Prevention of myocardial infarction and stroke in patients with intermittent claudication; effects of ticlopidine. Results from STIMS, the Swedish Ticlopidine Multicentre Study [published erratum appears in","volume":"228","author":"Janzon","year":"1990","journal-title":"J Intern Med"}],"container-title":["Clinical Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fclc.4960231106","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1002\/clc.4960231106\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T23:55:05Z","timestamp":1625183705000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/clc.4960231106"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,11]]},"references-count":37,"journal-issue":{"issue":"S6","published-print":{"date-parts":[[2000,11]]}},"URL":"https:\/\/doi.org\/10.1002\/clc.4960231106","relation":{},"ISSN":["0160-9289","1932-8737"],"issn-type":[{"value":"0160-9289","type":"print"},{"value":"1932-8737","type":"electronic"}],"subject":[],"published":{"date-parts":[[2000,11]]}}}